Tumour biology

#Cancer immunotherapy #Immunology / Virology & Vaccines #Moderna #mRNA #mRNA-based vaccines #Tumour biology

Vaccine for the ‘previously undruggable’ just a decade away 

In an exclusive interview with The Guardian, Moderna said that cancer and heart disease vaccines would be ready by 20301. The pharmaceutical firm also provided promising updates on mRNA-4157/V940, which targets different tumour types, at Moderna’s Vaccines Day on 24 March 20232.   The… Read More

#News

Macrophage
#Cancer research #Immunology #Macomics #Mass spectrometry / NMR #Oncology #Transcriptomics #Tumour biology #Tumour microenvironment (TME)

Scottish company will target macrophages to treat cancer

Newly published discoveries have revealed possibilities for the treatment of cancer by targeting tumour-associated macrophages (TAMs) in the tumour microenvironment (TME).  The founding scientists behind Edinburgh-based Macomics, Dr Luca Cassetta and Professor Jeff Pollard, detail the seminal discoveries in macrophage biology over the past 50 years in… Read More

#Cancer Research #News

#Cancer research #Immune system #Immunotherapy #Oncology #Tumour biology #Tumours

Avoiding detection – the cancer cells evading the body’s natural defence

Listen to this article on the DDW Podcast: DDW Editor Reece Armstrong explores recent research looking into why cancer cells are so effective at avoiding the body’s immune system. Scientists may have discovered clues to why cancer cells can avoid the body’s immune system in a study conducted by researchers at… Read More

#Cancer Research #Exclusive Content

Flow cytometry
#Cancer #Cancer research #Fibroblasts #Flow Cytometry #Immunology #Oncology #Tumour biology

Flow cytometry technologies and cancer associated fibroblasts

Listen to this article on the DDW podcast: Dr Amber Miller, Flow Cytometry Scientist, Fortis Life Sciences, says flow cytometry techniques can help our understanding of cancer associated fibroblasts but there is still work to be done. Inside any solid tumour there is high heterogeneity, and the types of tumour cells,… Read More

#Exclusive Content

#Cancer research #Tumour biology

Australian researchers identify new pathways to target breast cancer 

University of Queensland researchers have identified a pathway helping the breast cancer protein BRCA1 repair damaged DNA in a study that will inform future targeted therapies.  Professor Robert Parton, Professor Alpha Yap and Dr Kerrie-Ann McMahon from the university’s Institute for Molecular Bioscience (IMB) identified an association between two… Read More

#News

#Cancer research #In vitro #Oncology #Tumour biology

Self-assembling PeptiGels as a platform to recapitulate the tumour microenvironment in pancreatic cancer 

This paid-for advertorial by Manchester BioGel appeared in the DDW / ELRIG UK Drug Discovery 2021 supplement in DDW Volume 22, Issue 4 – Fall 2021   Communication of cells with their microenvironment is vital in understanding intracellular processes. Most matrices lack the mechanical and biochemical tuneability necessary to recreate the cancer microenvironment. Read More

#Exclusive Content

#Cancer immunotherapy #Funding #Immunology #Precision medicine #Tumour biology

Researchers receive $4 million for exceptional junior scientists

Two Mount Sinai cancer researchers will receive $4 million from the National Institutes of Health (NIH) Common Fund, which supports research by junior scientists around the United States. This will fund radiation oncology and CAR T cell cancer therapy research.  Deborah Marshall, Assistant Professor of Radiation Oncology at The Tisch… Read More

#News

#Cancer #Cancer immunotherapy #Cancer research #Clinical trials #Tumour biology

Cancer Awareness Month: Round up 

September 2021 has been Cancer Awareness Month for Blood, Childhood, Gynaecologic, Ovarian and Prostate Cancer, which affect millions of people around the world annually. Here is a round-up of eight of some of the innovative research and studies being done in order to tackle these various types of cancer. … Read More

#Cancer Research #News

#Cancer research #Research #Tumour biology

Proteogenomics study suggests treatment for pancreatic cancer 

A large, international collaboration led by researchers from the Johns Hopkins Kimmel Cancer Center has identified promising new targets for pancreatic cancer treatment and early diagnosis after examining various aspects of these tumours’ genes and proteins.  “Right now, patients with pancreatic cancer have very few options, and the wealth… Read More

#Cancer Research #News

#Cancer research #Clinical trials #Institute of Cancer Research #Tumour biology

Promise in treatment-resistant advanced ovarian cancer 

A new combination of targeted drugs for a type of ovarian cancer has shown promising results in an early clinical trial, shrinking tumours in half of patients. The combination of drugs, which both work by blocking signals cancer cells need to grow, could offer a new treatment option for women with… Read More

#Cancer Research #News #Trending News

#3D modelling #Cancer research #Cell therapy #Tumour biology

Prostate cancer therapy may fuel spread of bone tumours 

Anti-androgen therapy is commonly used to treat patients with advanced prostate cancer which has spread to the bones, however, the treatment may be fuelling bone cancer spread.  Dr Nathalie Bock from QUT Centre for Biomedical Technologies focused her research on bone metastases from breast and prostate cancers. Read More

#Cancer Research #News

#CAR-T #Cell therapy #GlobalData #Oncology #Tumour biology

Off-the-shelf potential for NK cell therapies for tumour treatment 

Natural killer (NK) cell therapies have the potential to be an effective, off-the-shelf treatment for a range of cancers. Analysis of NK cell therapies, currently in development, reveals that 57% of these are allogeneic therapies, and although development in haematological indications is more advanced, there are a high number of therapies… Read More

#Cancer Research #News

#Cancer immunotherapy #Cancer research #Clinical trials #Immuno-oncology #Immunology / Virology & Vaccines #Tumour biology

Collaboration to develop a novel cancer immunotherapy  

Terumo Blood and Cell Technologies and PhotonPharma have established a memorandum of understanding (MOU) for collaboration to develop Innocell, a novel tumour specific immunotherapy (a therapeutic vaccine)… Read More

#Cancer Research #News

#Immuno-oncology #Oncology #Pharma #Tumour biology

BridgeBio collaborates with Bristol Myers Squibb

BridgeBio Pharma has entered a clinical collaboration with Bristol Myers Squibb to evaluate the combination of BBP-398, a potentially best-in-class SHP2 inhibitor, with OPDIVO (nivolumab) in patients with advanced solid tumours with KRAS mutations with the hope of providing an effective new treatment option for patients with difficult-to-treat cancers.  The… Read More

#Cancer Research #News